Psychedelic Drugs Global Market Report 2022-2031 : Top Manufacturers, Industry Challenges, Business Strategies, Revenue Value And Competitive Landscape

The global psychedelic drugs market size is expected to grow from $3.62 billion in 2021 to $4.19 billion in 2022 at a compound annual growth rate (CAGR) of 15.6%. The global psychedelics market size is expected to reach $7.03 billion in 2026 at a CAGR of 14.2%.

The Business Research Company offers the Psychedelic Drug Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Request FREE SAMPLE COPY of this research study:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp

The psychedelic drug market consists of sales of psychedelic drugs by entities (organizations, sole traders, and partnerships) that are used to treat depression and post-traumatic stress disorder and also help with mental health diagnoses. Psychedelic drugs refer to hallucinogens. These drugs are a group of substances that usually alter and enhance perception, thinking processes, energy levels, and promote mental experiences. These include chemicals such as Lysergic acid diethylamid (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.

Some key psychedelic drug market players are Johnson & Johnson, Pfizer, Hikma Pharmaceuticals PLC, Roche Holding AG, Merck & Co Inc, Jazz Pharmaceuticals plc, COMPASS Pathways PLC, Celon Pharma S.A., Numinus Wellness Inc, AbbVie, Mylan N.V., Avadel, NeuroRx Inc., Klarisana, AstraZeneca, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Allergan Inc, Mota Ventures Corp., Seelos Therapeutics, Emmes Company, and Novatris International AG.

The countries covered in the global psychedelic drug market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global psychedelic drug market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Psychedelic drug Market Segmentation:
1) By Type:
Lysergic Acid Diethylamid (LSD)
Ketamine
Phencyclidine
Gamma Hydroxybutyric Acid (GHB)
Salvia

2) By Disease Indication:
Depression
PTSD

3) By Origin:
Natural
Synthetic

4) By Application:
Treatment-Resistant Depression
Post-Traumatic Stress Disorder
Narcolepsy
Panic Disorders

See more on the report at https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

The Report's Table Of Contents includes
1. Executive Summary
2. Psychedelic Drugs Market Characteristics
3. Psychedelic Drugs Market Trends And Strategies
4. Impact Of COVID-19 On Psychedelic Drugs
5. Psychedelic Drugs Market Size And Growth
………
27. Psychedelic Drugs Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Psychedelic Drugs Market
29. Psychedelic Drugs Market Future Outlook and Potential Analysis
30. Appendix

This report covers the trends and market dynamics of the psychedelic drug market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Directly purchase the report here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6345

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.